Central District

FAT Brands Inc. Reaches Agreement in Principle to Settle Class Action Litigation

Retrieved on: 
Wednesday, August 10, 2022 - 10:02pm

Brands Inc. (NASDAQ: FAT) (the Company) announced today that it has reached an agreement in principle to settle the consolidated securities class action lawsuit captioned In re FAT Brands Inc. Securities Litigation, Case No.

Key Points: 
  • Brands Inc. (NASDAQ: FAT) (the Company) announced today that it has reached an agreement in principle to settle the consolidated securities class action lawsuit captioned In re FAT Brands Inc. Securities Litigation, Case No.
  • FAT Brands Inc. (NASDAQ: FAT) is a leading global franchising company that strategically acquires, markets, and developsfast casual, quick-service, casual dining, and polished casual dining concepts aroundthe world.
  • There can be no assurance that the litigation will be finally resolved in accordance with the agreement in principle or at all.
  • All of these factors should be considered carefully and readers should not place undue reliance on the Companys forward-looking statements.

SHAREHOLER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Enochian Biosciences Inc. of Class Action Lawsuit and Upcoming Deadline – ENOB

Retrieved on: 
Wednesday, August 10, 2022 - 6:51pm

NEW YORK, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.

Key Points: 
  • NEW YORK, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.
  • To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

INVESTOR DEADLINE: Investors in Enochian Biosciences Inc. with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – ENOB

Retrieved on: 
Saturday, August 6, 2022 - 9:15am

The Enochian Biosciences class action lawsuit captioned Chow v. Enochian Biosciences Inc., No.

Key Points: 
  • The Enochian Biosciences class action lawsuit captioned Chow v. Enochian Biosciences Inc., No.
  • Enochian Biosciences and its top management have credited Serhat Gumrukcu (Gumrukcu), Enochian Biosciences co-founder, as the inventor of the technology and science behind Enochian Biosciences product pipeline.
  • A lead plaintiff acts on behalf of all other class members in directing the Enochian Biosciences class action lawsuit.
  • The lead plaintiff can select a law firm of its choice to litigate the Enochian Biosciences class action lawsuit.

Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Enochian Biosciences, Inc. (ENOB) Investors and Encourages Investors to Contact the Firm Before September 26, 2022

Retrieved on: 
Friday, August 5, 2022 - 5:03pm

Investors have until September 26, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until September 26, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • On May 25, 2022, the U.S. Department of Justice announced that Serhat Gumrukcu, the inventor and co-founder of Enochian, had been arrested and charged in a murder-for-hire conspiracy.
  • On this news, the price of Enochian shares declined by $2.17 per share, or approximately 36.9%, from $5.87 per share to close at $3.70 on May 25, 2022.
  • Kirby McInerney LLP is a New York-based plaintiffs law firm concentrating in securities, antitrust, whistleblower, and consumer litigation.

Social Media Victims Law Center Files Suit Against Social Media Giants for the Race-Driven Anguish Suffered by One Small-Town Family

Retrieved on: 
Tuesday, August 2, 2022 - 6:22pm

Without his fathers knowledge or consent, KLJ opened his first YouTube account when he was 10 and quickly became addicted.

Key Points: 
  • Without his fathers knowledge or consent, KLJ opened his first YouTube account when he was 10 and quickly became addicted.
  • She began using all four social media products every chance she got, and her addiction to these social media products worsened.
  • The Social Media Victims Law Center (SMVLC), www.socialmediavictims.org , was founded in 2021 to hold social media companies legally accountable for the harm they inflict on vulnerable users.
  • Matthew P. Bergman is an attorney, law professor, philanthropist and community activist who has recovered over $1 billion on behalf of his clients.

INVESTOR NOTICE: Enochian Biosciences Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - ENOB

Retrieved on: 
Tuesday, August 2, 2022 - 3:10pm

The Enochian Biosciences class action lawsuit captioned Chow v. Enochian Biosciences Inc., No.

Key Points: 
  • The Enochian Biosciences class action lawsuit captioned Chow v. Enochian Biosciences Inc., No.
  • Enochian Biosciences and its top management have credited Serhat Gumrukcu (Gumrukcu), Enochian Biosciences co-founder, as the inventor of the technology and science behind Enochian Biosciences product pipeline.
  • A lead plaintiff acts on behalf of all other class members in directing the Enochian Biosciences class action lawsuit.
  • The lead plaintiff can select a law firm of its choice to litigate the Enochian Biosciences class action lawsuit.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Enochian Biosciences Inc. of Class Action Lawsuit and Upcoming Deadline – ENOB

Retrieved on: 
Monday, August 1, 2022 - 6:02pm

NEW YORK, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.

Key Points: 
  • NEW YORK, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.
  • To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

ENOB CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Enochian Biosciences, Inc.

Retrieved on: 
Monday, August 1, 2022 - 4:45pm

The Law Offices of Frank R. Cruz announces that it has filed a class action lawsuit in the United States District Court for the Central District of California, captioned Manici v. Enochian Biosciences, Inc., et al., Case No.

Key Points: 
  • The Law Offices of Frank R. Cruz announces that it has filed a class action lawsuit in the United States District Court for the Central District of California, captioned Manici v. Enochian Biosciences, Inc., et al., Case No.
  • Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the Exchange Act).
  • Investors are hereby notified that they have until September 26, 2022 to move the Court to serve as lead plaintiff in this action.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

17 EDUCATION & TECHNOLOGY GROUP INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed against 17 Education & Technology Group Inc. in the United States District Court for the C

Retrieved on: 
Monday, August 1, 2022 - 4:19am

All investors who purchased the ADRs of 17 Education & Technology Group Inc. and incurred losses are urged to contact the firm immediately at classmember@whafh.com or (800) 575-0735 or (212) 545-4774.

Key Points: 
  • All investors who purchased the ADRs of 17 Education & Technology Group Inc. and incurred losses are urged to contact the firm immediately at classmember@whafh.com or (800) 575-0735 or (212) 545-4774.
  • You may obtain additional information concerning the action or join the case on our website, www.whafh.com .
  • Please contact Wolf Haldenstein to learn more about your rights as an investor in the ADRs of 17 Education & Technology Group Inc.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Enochian Biosciences, Inc. (ENOB) Investors

Retrieved on: 
Friday, July 29, 2022 - 11:18pm

Investors have until September 26, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until September 26, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Enochian is a biopharmaceutical company that focuses on identifying, developing, manufacturing, and commercializing gene-modified cell therapy.
  • Kirby McInerney LLP is a New York-based plaintiffs law firm concentrating in securities, antitrust, whistleblower, and consumer litigation.
  • The firms efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars.